Cardiac output = stroke volume x heart rate

Left ventricular ejection fraction = (stroke volume / end diastolic LV volume ) x 100%

Stroke volume = end diastolic LV volume – end systolic LV volume

Pulse pressure = Systolic Pressure – Diastolic Pressure

Systemic vascular resistance = mean arterial pressure / cardiac output
Factors that increase pulse pressure include:
-a less compliant aorta (this tends to occur with advancing age)
-increased stroke volume

pH is the negative log to the base 10 of hydrogen ion concentration:

So, what power produces the answer?

pH = – log10 [H+]

Making [H+] the subject:

[H+] = 10-pH

Substituting, [H+] = 10-7

One nanomole = 1 x 10-9 or 0.000000001

10-7 = 1x 0.0000001 or 10 x 0.00000001 or 100 x 0.000000001

100 nanomole

Crystalloids recommended for fluid resuscitation include 0.9% N saline and Hartmann’s solution(a physiological solution). 0.9% N. saline is not a physiological solution for the following reasons:

Compared with the normal range of 98-102 mmol/L, its chloride concentration is high (154 mmol/L)
It lacks calcium, magnesium, glucose and potassium
It does not have bicarbonate or bicarbonate precursor buffer necessary to maintain plasma pH within normal limits

There is a difference in the activity (concentration) of strong ions at a physiological pH. This imbalance can explain abnormalities of acid base balance. A normal strong ion difference (SID) is in the order of 40.

SID = ([Na+] + [K+] + [Ca2+] + [Mg2+]) – ([Cl-] + [lactate] + [SO42-])

This imbalance is made up with the weaker anions to maintain electrical neutrality.
Administration of a large volume of 0.9% normal saline during resuscitation results in excessive chloride administration and this impairs renal bicarbonate reabsorption. The SID of 0.9% normal saline is 0 (Na+ = 154mmol/L and Cl- = 154mmol/L = 154 – 154 = 0). A large volume of NS will decrease the plasma SID causing an acidosis.

Other causes of a hyperchloremic acidosis are:

Diabetic ketoacidosis
Total Parenteral Nutrition
Overdose of ammonium chloride and hydrochloric acid
Gastrointestinal losses of bicarbonate like in diarrhoea and pancreatic fistula
Proximal renal tubular acidosis with failure of bicarbonate reabsorption

The incidence of a disease is the number of new cases of the disease in a population over a defined time period.

The prevalence of a disease is the number of cases of the disease in a population over a defined time period describes. It is NOT the number of new cases.

The number of new cases of a disease only, has no denominator (time period or population) from which to derive an incidence.

The number of new cases of a disease seeking medical treatment is the incidence of patients seeking medical treatment NOT the incidence of the disease in a population.

The death rate from a disease is the number of patients dying from the disease in a population.

The trochlear nerve (CN IV) is the fourth and smallest cranial nerve. It’s role is to provide somatic motor innervation of the superior oblique muscle which is responsible for oculomotion.

Injury to the trochlear nerve will result in vertical diplopia, which worsens when looking downwards or inwards. This diplopia presents as an upward deviation of the eye with a head tilt away from the site of the lesion.

The abducens nerve (CN VI) provides somatic motor innervation for the lateral rectus muscle which functions to abduct the eye. Injury to this nerve will cause diplopia and an inability to abduct the eye, causing the patient to have to rotate their head to look sideways.

The facial nerve (CN VII) provides sensory, motor and parasympathetic innervations. It’s motor aspect controls the muscles of facial expression. Damage will cause paralysis of facial expression.

The oculomotor nerve (CN III) provides motor and parasympathetic innervations. Its motor component controls most of the other extraocular muscles. Damage to it will result in ptosis, dilatation of the pupil and a down and out eye position.

The ophthalmic division of the trigeminal nerve (CN VI) is responsible for sensory innervation of skin, mucous membranes and sinuses of the upper face and scalp.

With regards to compensatory response to blood loss, the following sequence of events take place:

1. Decrease in venous return, right atrial pressure and cardiac output
2. Baroreceptor reflexes (carotid sinus and aortic arch) are immediately activated
3. There is decreased afferent input to the cardiovascular centre in medulla. This inhibits parasympathetic reflexes and increases sympathetic response
4. This results in an increased cardiac output and increased SVR by direct sympathetic stimulation. There is increased circulating catecholamines and local tissue mediators (adenosine, potassium, NO2)
5. Fluid moves into the intravascular space as a result of decreased capillary hydrostatic pressure absorbing interstitial fluid.

A slower response is mounted by the hypothalamus-pituitary-adrenal axis.
6. Reduced renal blood flow is sensed by the intra renal baroreceptors and this stimulates release of renin by the juxta-glomerular apparatus.
7. There is cleavage of circulating Angiotensinogen to Angiotensin I, which is converted to Angiotensin II in the lungs (by Angiotensin Converting Enzyme ACE)

Angiotensin II is a powerful vasoconstrictor that sets off other endocrine pathways.
8. The adrenal cortex releases Aldosterone
9. There is antidiuretic hormone release from posterior pituitary (also in response to hypovolaemia being sensed by atrial stretch receptors)
10. This leads to sodium and water retention in the distal convoluted renal tubule to conserve fluid
Fluid conservation is also aided by an increased amount of cortisol which is secreted in response to the increase in circulating catecholamines and sympathetic stimulation.

Drug elimination is the termination of drug action, and may involve metabolism into inactive state and excretion out of the body. Duration of drug action is determined by the dose administered and the rate of elimination following the last dose.

There are two types of elimination: first-order and zero-order elimination.

In first-order elimination, the rate of elimination is proportionate to the concentration; the concentration decreases exponentially over time. It observes the characteristic half-life elimination, where the concentration decreases by 50% for every half-life.

In zero-order elimination, the rate of elimination is constant regardless of concentration; the concentration decreases linearly over time. A constant amount of the drug being excreted over time, and it occurs when drugs have saturated their elimination mechanisms.

Since phenytoin is observed in elevated levels, the elimination mechanisms for it has been saturated and, thus, will have to undergo zero-order elimination.

The bispectral index (BIS) is one of several systems used in anaesthesiology as of 2003 to measure the effects of specific anaesthetic drugs on the brain and to track changes in the patient’s level of sedation or hypnosis. It is a complex mathematical algorithm that allows a computer inside an anaesthesia monitor to analyse data from a patient’s electroencephalogram (EEG) during surgery. It is a dimensionless number (0-100) that is a summative measurement of time domain, frequency domain and high order spectral parameters derived from electroencephalogram (EEG) signals.

Sleep and anaesthesia have similar behavioural characteristics but are physiologically different but BIS monitors can be used to measure sleep depth. With increasing sleep depth during slow-wave sleep, BIS levels decrease. This correlates with changes in regional cerebral blood flow when measured using positron emission tomography (PET).

BIS shows a dose-response relationship with the intravenous and volatile anaesthetic agents. Opioids produce a clinical change in the depth of sedation or analgesia but fail to produce significant changes in the BIS. Ketamine increases CMRO2 and EEG activity.

BIS is unable to predict movement in response to a surgical stimulus. Some of these are spinal reflexes and not perceived by the cerebral cortex.

BIS is used during cardiopulmonary bypass to measure depth of anaesthesia and an index of cerebral perfusion. However, it cannot predict subtle or significant cerebral damage.

Work up bias involves comparing the novel diagnostic test with the current standard test. A portion of the patients undergo the standard test while others undergo the new test as the standard test is costly. The result can be alteration in specify and sensitivity.

Recall bias is specifically appropriate to the case control studies that is when ever the memories retrieved by the participants differ in accuracy.

Not publishing the results of a valid study just because they are negative or uninteresting can be termed as publication bias.

When information gathering is ill suited with respect to time i.e. collecting the data regarding a fatal disease many years after the death of its patients, it is termed as Late – look bias.

The case in point is an instance of lead time bias when upon comparing two tests, one is able to detect the condition earlier than the other but the overall outcome doesn’t change. There is a possibility that this will make the survival rates for the newer test look more promising.

The ideal volatile agent for a day case surgery inhalational induction should have the following characteristics:

It has a pleasant scent that is not overpowering.
Breathing difficulties, coughing, or laryngeal spasm are not caused by this substance.
The action has a quick onset and a quick reversal.

The blood:gas partition coefficient is a physicochemical property of a volatile agent that determines the onset and offset of anaesthesia. The greater an agent’s insolubility in plasma, the faster its alveolar concentration rises.

The blood gas partition coefficients of the most commonly used volatile anaesthetic agents are as follows:
Halothane 2.3
Desflurane 0.45
Sevoflurane 0.6
Nitrous oxide 0.47
Isoflurane 1.4

Although halothane has a pleasant odour, it has a slower offset than sevoflurane.

Sevoflurane also has a pleasant odour and is less likely than desflurane to cause airway irritation and breath-holding.

The choice of agent for inhalational induction is unaffected by potency/lipid solubility measures such as the oil: gas partition coefficient and MAC.

In this case, an agent’s saturated vapour pressure is irrelevant.